What do systematic reviews say?

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 273 participants
  Low

Intervention not reported

The review found no eligible studies for this question.

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

The review found no eligible studies for this question.

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 3990 participants
  Low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 841 participants
  Moderate

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  15 studies · 1639 participants
  Very low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  57 studies · 12260 participants
  Moderate

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  7 studies · 1259 participants
  Very low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  14 studies · 1529 participants
  Low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  10 studies · 1656 participants
  Low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 participants
  GRADE not reported

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 904 participants
  Low

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  22 studies · 3679 participants
  Moderate

Intervention not reported

• Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta‐analysis 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 99 participants
  Low

Abiraterone + ADT vs ADT only

Abiraterone + ADT leads to lower time to death from any cause compared with ADT alone (high certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  HR 0.64 [0.56, 0.73]
  2 studies · 2201 participants
  High

Abiraterone + ADT vs ADT only

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 838 participants
  Moderate

Abiraterone + ADT vs ADT only

Abiraterone + ADT leads to higher grades III to V adverse events (severe and life threatening, as per… compared with ADT alone (high certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  RR 1.34 [1.22, 1.47]
  1 study · 1199 participants
  High

Abiraterone + ADT vs ADT only

Abiraterone + ADT probably leads to lower time to death due to prostate cancer measured at a median compared with ADT alone (moderate certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  HR 0.58 [0.5, 0.68]
  2 studies · 2201 participants
  Moderate

Abiraterone + ADT vs ADT only

Abiraterone + ADT probably leads to lower time to disease progression measured at a median compared with ADT alone (moderate certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  HR 0.35 [0.26, 0.49]
  2 studies · 2097 participants
  Moderate

Abiraterone + ADT vs ADT only

Abiraterone + ADT probably leads to higher discontinued treatment due to adverse events measured at a median compared with ADT alone (moderate certainty).

• Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for… 2020 · Cochrane Headline outcomes only
  RR 1.5 [1.17, 1.92]
  1 study · 1199 participants
  Moderate